These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38857636)

  • 1. Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders - A systematic review and meta-analysis.
    Murphy J; Zierotin A; Mongan D; Healy C; Susai SR; O'Donoghue B; Clarke M; O'Connor K; Cannon M; Cotter DR
    Brain Behav Immun; 2024 Aug; 120():327-338. PubMed ID: 38857636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis.
    Lee JM; Yang JW; Kronbichler A; Eisenhut M; Kim G; Lee KH; Shin JI
    J Immunol Res; 2019; 2019():5679518. PubMed ID: 31089477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between plasma inflammatory markers and psychotic disorder, depressive disorder and generalised anxiety disorder in early adulthood: A nested case-control study.
    Mongan D; Raj Susai S; Föcking M; Byrne JF; Zammit S; Cannon M; Cotter DR
    Brain Behav Immun; 2023 Jul; 111():90-100. PubMed ID: 37004760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia.
    Genc A; Kalelioglu T; Karamustafalioglu N; Tasdemir A; Genc ES; Akkus M; Emul M
    Psychiatry Res; 2016 Feb; 236():179-181. PubMed ID: 26774189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.
    Kostopoulou E; Kalavrizioti D; Davoulou P; Sinopidis X; Papachristou E; Goumenos DS; Dimitriou G; Spiliotis BE; Papasotiriou M
    Eur J Pediatr; 2024 May; 183(5):2383-2389. PubMed ID: 38448612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis.
    Shuai T; Pei Jing Y; Huang Q; Xiong H; Liu J; Zhu L; Yang K; Jian L
    BMJ Open; 2019 Oct; 9(10):e031812. PubMed ID: 31594897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms.
    Bigseth TT; Engh JA; Egeland J; Andersen E; Andreassen OA; Bang-Kittilsen G; Falk RS; Holmen TL; Lindberg M; Mordal J; Nielsen J; Steen NE; Ueland T; Vang T; Fredriksen M
    BMC Psychiatry; 2021 Oct; 21(1):527. PubMed ID: 34702245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.
    Nielsen J; Røge R; Pristed SG; Viuff AG; Ullum H; Thørner LW; Werge T; Vang T
    Schizophr Bull; 2015 May; 41(3):764-71. PubMed ID: 25154621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
    Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
    Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality.
    Törnkvist PBS; Haupt TH; Rasmussen LJH; Ladelund S; Toft U; Pisinger C; Eugen-Olsen J
    Br J Nutr; 2019 Mar; 121(6):699-708. PubMed ID: 30626457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis.
    Petersen JEV; Kallemose T; Barton KD; Caspi A; Rasmussen LJH
    BMJ Open; 2020 Jul; 10(7):e036125. PubMed ID: 32690515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
    Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
    Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
    Rasmussen LJH; Petersen JEV; Eugen-Olsen J
    Front Immunol; 2021; 12():780641. PubMed ID: 34925360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of soluble urokinase-type plasminogen activator receptor in patients with acute coronary syndrome: A systematic review and meta-analysis.
    Pruc M; Jannasz I; Swieczkowski D; Procyk G; Gasecka A; Rafique Z; Chirico F; Bragazzi NL; Jaguszewski MJ; Wysocki J; Szarpak L
    Cardiol J; 2024; 31(4):564-572. PubMed ID: 37772350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis.
    Ni W; Han Y; Zhao J; Cui J; Wang K; Wang R; Liu Y
    Sci Rep; 2016 Dec; 6():39481. PubMed ID: 27991579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Shuai T; Yan P; Xiong H; Huang Q; Zhu L; Yang K; Liu J
    Biomed Res Int; 2019; 2019():6927456. PubMed ID: 31886242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Huang Q; Xiong H; Shuai T; Wang Y; Zhang C; Zhang M; Zhu L; Lu J; Liu J
    Ther Adv Respir Dis; 2020; 14():1753466620938546. PubMed ID: 32643535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
    Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
    Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.